KADIAN 200 mg (Morphine Sulfate Extended Release 200 mg)
Pill with imprint KADIAN 200 mg is Brown, Capsule-shape and has been identified as Morphine Sulfate Extended Release 200 mg. It is supplied by Actavis.
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for KADIAN 200 mg
Morphine Sulfate Extended Release
- Imprint
- KADIAN 200 mg
- Strength
- 200 mg
- Color
- Brown
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis
- National Drug Code (NDC)
- 00228-3508
Related Images for "KADIAN 200 mg"
More about morphine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 335 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (10)
Consumer resources
- Patient Information
- Morphine injection
- Morphine (Advanced Reading)
- Morphine Epidural (Advanced Reading)
- Morphine Injection (Advanced Reading)
- Other brands
- MS Contin, Roxanol, Kadian, Duramorph, ... +9 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.